Literature DB >> 22301063

Ten-year relative survival and causes of death in elderly patients treated with R-CHOP or CHOP in the GELA LNH-985 trial.

Nicolas Mounier1, Natacha Heutte, Catherine Thieblemont, Josette Briere, Philippe Gaulard, Pierre Feugier, Hervé Ghesquieres, Eric Van Den Neste, Daniela Robu, Herve Tilly, Reda Bouabdallah, Violaine Safar, Bertrand Coiffier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22301063     DOI： 10.1016/j.clml.2011.11.004

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN： 2152-2669


× No keyword cloud information.
  4 in total

Review 1.  Are we ready to stratify treatment for diffuse large B-cell lymphoma using molecular hallmarks?

Authors:  Sarah Barton; Eliza A Hawkes; Andrew Wotherspoon; David Cunningham
Journal:  Oncologist       Date:  2012-10-18

Review 2.  Oncological Treatment-Related Fatigue in Oncogeriatrics: A Scoping Review.

Authors:  Louise André; Gabriel Antherieu; Amélie Boinet; Judith Bret; Thomas Gilbert; Rabia Boulahssass; Claire Falandry
Journal:  Cancers (Basel)       Date:  2022-05-17       Impact factor: 6.575

3.  Diffuse large B-cell lymphoma in elderly: Experience from a tertiary care oncology center in South India.

Authors:  K N Lokesh; M C Suresh Babu; K C Lakshmaiah; K Govind Babu; Smitha C Saldanha; D Loknatha; Linu Abraham Jacob; S Vishwanath; C S Premalatha; P R Kiran
Journal:  South Asian J Cancer       Date:  2017 Apr-Jun

Review 4.  Rituximab-Based Therapy in Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients: Individualized Risk-Adapted Therapy Approach Using Molecular Subtypes.

Authors:  Lei Fan; Lindong Li; Yiqun Zhou; Jianyong Li
Journal:  J Hematol (Brossard)       Date:  2017-07-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.